Drug Approval | October 30, 2025
Granules India’s facility secures FDA EIR with 'VAI’
The EIR was issued with an inspection classification of Voluntary Action Indicated (VAI) post the inspection conducted in June 2025
The EIR was issued with an inspection classification of Voluntary Action Indicated (VAI) post the inspection conducted in June 2025
Hyperion results presented at ERS 2025 and simultaneously published in the New England Journal of Medicine
The receipt of EIR reaffirms the company's commitment to maintaining global quality standards
Apollo AyurVAID’s product line features clinically proven formulations certified safe by NABL-accredited laboratories for heavy metals, aflatoxins, microbial content
Surpassing 1,000 Company Owned Company Operated stores
WINREVAIR significantly reduced the risk of clinical worsening events in recently diagnosed PAH patients over 70 percent of whom were on double background therapy
CRL shall invest another Rs. 200 crore for creation of additional beds
The company has also launched its first three 24*7 pharmacy stores via COCO model in Bengaluru
This e-commerce platform is launched as a hyperlocal model
We will continue to expand our range of purified excipients, offering pharmaceutical companies a dependable partner
Subscribe To Our Newsletter & Stay Updated
